Table 3.

Adverse event analysis in the two groups.

	Standard group (n = 95)	Research group (n = 62)	χ 2	P
Recurrence	0 (0.00)	0 (0.00)	—	—
Intracranial hemorrhage	3 (3.16)	2 (3.23)	0.441	0.659
Gastrointestinal bleeding	2 (2.11)	1 (1.61)	0.376	0.707
Venous thrombosis	3 (3.16)	1 (1.61)	0.082	0.934
Thrombocytopenia	2 (2.11)	1 (1.61)	0.376	0.707
Abdominal discomfort	3 (3.16)	2 (3.23)	0.441	0.659
Elevated liver enzymes	1 (1.05)	0 (0.00)	Fisher	>0.999
Depression	7 (7.37)	5 (4.84)	0.113	0.737
Total incidence	21 (22.11)	12 (19.35)	0.171	0.679